格隆汇2月11日丨力诺药包(301188.SZ)公布，根据山东力诺医药包装股份有限公司日常生产经营的需 要，公司拟与山东力诺实业有限公司（简称"力诺实业"）签署《硼砂订货合同》，总金额为含税价1490 万元。力诺实业系公司控股股东之控股股东力诺集团股份有限公司的全资子公司，为公司的关联法人， 根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第7号——交易 与关联交易》和《公司章程》等有关规定，本次交易属于关联交易事项。 ...

Core Viewpoint - Yiming Pharmaceutical (002826.SZ) announced a restricted stock incentive plan for 2026, aiming to enhance employee motivation and align their interests with shareholders [1] Group 1: Incentive Plan Details - The incentive plan proposes to grant a total of 3.4038 million restricted shares, which accounts for approximately 1.79% of the company's total share capital of 190.677750 million shares as of the announcement date [1] - A total of 26 individuals will be granted restricted shares under this plan, indicating a targeted approach to incentivizing key personnel [1] - The initial grant price for the restricted shares is set at 10.23 yuan per share, establishing a clear entry point for the incentive [1]

Core Viewpoint - The company, Siyuan Electric (002028.SZ), has submitted an application for the issuance of overseas listed foreign shares (H-shares) and for listing on the main board of the Hong Kong Stock Exchange on February 11, 2026 [1] Group 1 - The application materials were prepared and published in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange [1] - The published application materials are in draft form and may be updated and revised as necessary [1]

Core Viewpoint - The company, Zhilai Technology (300771.SZ), has announced its first employee stock ownership plan, aiming to raise a total of up to 38.6 million yuan, including reserved portions [1] Group 1: Employee Stock Ownership Plan Details - The employee stock ownership plan is designed to raise funds with a maximum amount of 38.6 million yuan, with each share priced at 1 yuan [1] - The total number of shares available under this plan is capped at 38.6 million shares, with the final amount depending on actual payment situations [1] - The plan will involve up to 230 participants, including directors, senior management, middle management, and key department employees, with a total of 6 directors and senior management included [1]

格隆汇2月11日丨华盛昌(002980.SZ)公布，公司结合当时市场环境、行业发展趋势及公司实际情况等因 素制定了"总部及研发中心建设项目"，公司在项目立项及延期时进行了审慎、充分的研究与论证，但由 于市场和行业环境发生了较大变化，南山区总部联建大厦建设进度不及预期。同时，外部市场环境发生 显著变化，若继续大规模投入总部联建大厦建设，不仅难以实现预期经济效益，还将占用公司大量营运 资金。根据市场环境变化、募集资金投资项目客观情况及公司业务经营现状，公司拟终止"总部及研发 中心建设项目"。 本次募投项目终止后，公司拟将该募投项目终止后的结余募集资金（含募集资金账户中剩余的11,074.03 万元、后续政府退还款、理财收益及存款利息，具体以实际结转时金额为准）永久补充流动资金，用于 公司日常生产经营及业务发展。上述募投项目终止及剩余募集资金永久补充流动资金后，公司董事会将 授权相关人员办理专户注销事项，专户注销后，公司与保荐机构、募集资金存放银行签订的募集资金监 管协议随之终止。 ...

格隆汇2月11日｜美国健康保险公司Humana预计2026年调整后每股收益至少为9美元，市场预期为11.87 美元。 ...

格隆汇2月11日｜现货黄金站上5100美元/盎司关口，为1月30日以来首次，日内涨1.54%。 ...

Core Viewpoint - China National Pharmaceutical Modern (600420.SH) announced participation in the national centralized procurement for drugs whose agreements have expired, with 51 drugs from the company and its subsidiaries proposed for selection in the continuation procurement [1] Group 1: Procurement Details - The continuation procurement is organized for drugs from the first to eighth batches of national centralized procurement agreements that have expired [1] - The procurement cycle for the selected drugs will last from the execution of the selection results until December 31, 2028 [1] - The procurement office has not disclosed specific supply prices and quantities for the selected drugs [1] Group 2: Market Impact - Overall, the continuation procurement is expected to maintain price stability, with some drug prices potentially decreasing further [1] - Medical institutions will prioritize the use of the selected drugs during the procurement cycle, ensuring the completion of the agreed procurement volume [1] - The signing of sales contracts for the selected drugs is anticipated to solidify the company's existing market share and enhance its brand influence and market competitiveness [1] - The aforementioned matters are not expected to have a significant impact on the company's current operating performance [1]

Core Viewpoint - Colin Electric (603050.SH) announced that Mr. Li Yanru and Mr. Qu Guowang plan to reduce their holdings by a total of up to 6.0496 million shares, representing a maximum of 1.50% of the company's total share capital [1] Group 1 - Mr. Li Yanru intends to reduce his holdings through centralized bidding and block trading, with a maximum reduction of 6.0496 million shares [1] - Mr. Qu Guowang also plans to reduce his holdings through centralized bidding and block trading, with a maximum reduction of 6.0496 million shares [1] - The reduction plan will be executed within three months starting from 15 trading days after the announcement date [1] Group 2 - The reduction price will be determined based on the market price at the time of the reduction, and it will not be lower than the issuance price (after the ex-rights) [1]

格隆汇2月11日丨沃尔核材(002130.SZ)公布，公司已确定本次H股发行的最终价格为每股20.09港元（不 包括1%经纪佣金、0.0027%香港证券及期货事务监察委员会交易征费、0.00565%香港联交所交易费及 0.00015%香港会计及财务汇报局交易征费）。公司本次发行的H股将于2026年2月13日在香港联交所主 板挂牌并开始上市交易。 ...